December 18, 2014 10:26 PM ET

Pharmaceuticals

Company Overview of Xenova Biomedix Ltd.

Company Overview

Xenova Biomedix Ltd. is a biotechnology company that develops therapeutic drugs for the treatment of cancer and inflammatory diseases. It also provides clinical trials, consultancy, and patent management services. The company was formerly known as KS Biomedix Holdings plc. As a result of its acquisition by Xenova Group plc, the name of KS Biomedix Holdings plc was changed. The company is headquartered in Guildford, United Kingdom. As of September 12, 2003, Xenova Biomedix Ltd. is a subsidiary of Xenova Group plc.

1 Occam Court

The Surrey Research Park

Guildford,  GU2 7HJ

United Kingdom

Phone:

44 1483 307500

Fax:

44 1483 307501

Key Executives for Xenova Biomedix Ltd.

Executive Director
Age: 58
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Medeva Ltd. Europe
Generics [UK] Limited Europe
Cardinal Health U.K. 433 Limited Europe
Alliance Pharmaceuticals Ltd Europe
DCC Health & Beauty Solutions Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xenova Biomedix Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.